Gender dimorphism in skeletal muscle leptin receptors, serum leptin and insulin sensitivity by Guerra, Borja et al.
Gender Dimorphism in Skeletal Muscle Leptin Receptors,
Serum Leptin and Insulin Sensitivity
Borja Guerra1, Teresa Fuentes1, Safira Delgado-Guerra1, Amelia Guadalupe-Grau1, Hugo Olmedillas1,
Alfredo Santana1,2,3, Jesus Gustavo Ponce-Gonzalez1, Cecilia Dorado1, Jose´ A. L. Calbet1*
1Department of Physical Education, University of Las Palmas de Gran Canaria, Campus Universitario de Tafira s/n, Las Palmas de Gran Canaria, Spain, 2Genetic Unit,
Chilhood Hospital-Materno Infantil de Las Palmas, del Sur s/n, Las Palmas de Gran Canaria, Spain, 3 Research Unit, Hospital de Gran Canaria Dr. Negrı´n, Bco Ballena s/n, Las
Palmas de Gran Canaria, Spain
Abstract
To determine if there is a gender dimorphism in the expression of leptin receptors (OB-R170, OB-R128 and OB-R98) and the
protein suppressor of cytokine signaling 3 (SOCS3) in human skeletal muscle, the protein expression of OB-R, perilipin A,
SOCS3 and alpha-tubulin was assessed by Western blot in muscle biopsies obtained from the m. vastus lateralis in thirty-
four men (age = 27.166.8 yr) and thirty-three women (age= 26.766.7 yr). Basal serum insulin concentration and HOMA
were similar in both genders. Serum leptin concentration was 3.4 times higher in women compared to men (P,0.05) and
this difference remained significant after accounting for the differences in percentage of body fat or soluble leptin receptor.
OB-R protein was 41% (OB-R170, P,0.05) and 163% (OB-R128, P,0.05) greater in women than men. There was no
relationship between OB-R expression and the serum concentrations of leptin or 17b-estradiol. In men, muscle OB-R128
protein was inversely related to serum free testosterone. In women, OB-R98 and OB-R128 were inversely related to total
serum testosterone concentration, and OB-R128 to serum free testosterone concentration. SOCS3 protein expression was
similar in men and women and was not related to OB-R. In women, there was an inverse relationship between the logarithm
of free testosterone and SCOS3 protein content in skeletal muscle (r =20.46, P,0.05). In summary, there is a gender
dimorphism in skeletal muscle leptin receptors expression, which can be partly explained by the influence of testosterone.
SOCS3 expression in skeletal muscle is not up-regulated in women, despite very high serum leptin concentrations
compared to men. The circulating form of the leptin receptor can not be used as a surrogate measure of the amount of
leptin receptors expressed in skeletal muscles.
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Introduction
Leptin is a hormone secreted primarily by adipocytes from the
white adipose tissue and by the stomach [1,2] with pleiotropic
effects on appetite, energy expenditure, fat deposition, hemato-
poiesis, angiogenesis, blood pressure, immune function, blood
clotting, bone mass, and reproduction [1]. In lean, but not in obese
human skeletal muscle, leptin is able to stimulate fatty acid
oxidation [3], suggesting that triglyceride accumulation and
lipotoxicity in obesity could be caused by changes in the leptin
signaling cascade.
There are at least six isoforms of leptin receptors (OB-Rs)
generated by mRNA alternative splicing and/or proteolytic
processing of the subsequent protein products [4]. These isoforms
are divisible into three classes: secreted, short and long. The
secreted isoform, also named soluble leptin receptor (sOB-R), is
mostly secreted into the bloodstream by the liver [5]. The sOB-R
binds circulating leptin and regulates the concentration of free
leptin [6]. The short and long isoforms contain identical
extracellular and transmembrane domains and differ in the length
of the intracellular amino acid sequence [1,7]. The long form of
the leptin receptor (OB-Rb) has a ,300 residues intracellular
domain, highly conserved in several species, and is critical for the
effects of this hormone [7]. In fact, the db/db mice lacking OB-Rb,
are phenotypically similar to the leptin-deficient ob/ob mice and to
the db3j/db3j mice (which are deficient in all leptin receptor
isoforms) [8].
Expression of OB-R mRNA have also been found in non-
neuronal tissues [9] such as bone, heart, liver, lung, adrenal glands,
testes, spleen, small intestine, pancreatic islets, placenta, adipose
tissue and skeletal muscle [10–15]. We have recently shown the
presence of OB-R protein in human skeletal muscle, adipose tissue
and hypothalamus [16].
The concentration of leptin in plasma is proportional to the size
of the fat mass but for a given amount of fat mass (and BMI),
women have a higher concentration of circulating free leptin
[17,18,19], i.e. women may be more resistant to the effects of
leptin. High leptin levels could down-regulate leptin receptors,
since expression (mRNA) of the long (OB-Rb) and short (OB-Ra)
isoforms of the leptin receptor are markedly reduced in the
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hypothalamus and liver of obese rats, which have enhanced
plasma leptin concentration [20]. OB-R expression appears to be
reduced by testosterone in Leydig cells [21], while estradiol
administration to ovariectomized rats increases OB-R protein
expression in skeletal muscles [22]. Leptin may also down-regulate
leptin signaling in the target tissues by inducing the protein
suppressor of cytokine signaling 3 (SOCS3), which blunts JAK-2-
dependent leptin signaling [23] and causes leptin resistance in the
skeletal muscle [24].
We hypothesized that the high level of circulating leptin
observed in women may result in down-regulation of leptin
receptors in skeletal muscle or increased SOCS3 protein levels. In
addition, we also hypothesized that leptin receptors expression in
skeletal muscle will be inversely related to testosterone concentra-
tion and directly related to estradiol concentration in both genders.
Accordingly, our main purpose was to determine if there is a
gender dimorphism in leptin receptor expression in human skeletal
muscles. A second purpose was to assess if such dimorphism (if
present) is associated with some gender-related factors such as,
circulating levels of leptin, testosterone or estradiol concentrations.
A third purpose was to determine if the high leptin levels of
women are associated to increased SOCS3 protein levels in
skeletal muscles. Finally, we aimed at determining if soluble leptin
receptor may serve as a surrogate measure of the leptin receptor
protein expression in skeletal muscles.
Materials and Methods
Materials
The Complete protease inhibitor cocktail was obtained from
Roche Diagnostics (Mannheim, Germany). The polyclonal rabbit
anti-human leptin receptor antibody that recognizes the human
leptin receptor was obtained from Linco Research (St. Charles,
Missouri, USA). The polyclonal rabbit anti-human SOCS3
antibody was obtained from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). The monoclonal mouse anti-alpha-tubulin
antibody was obtained from Biosigma (Madrid, Spain). The
secondary HRP-conjugated goat anti-rabbit and donkey anti-
mouse antibodies were from Jackson ImmunoReseach (West
Grove, PA, USA). The Hybond-P transfer membranes, Hyperfilm
ECL and the ECL plus Western Blotting Detection System were
from Amersham Biosciences (Little Chalfont, Buckinghamshire,
UK). The ChemiDoc XRS System and the image analysis
software Quantity One were obtained from Bio-Rad Laborato-
ries (Hemel Hempstead Hertfordshire, UK).
Participants
Thirty three healthy men and thirty three healthy women agree
to participate in this investigation. The study population was
composed by physical education students and police officers. Their
levels of physical activity span from an almost sedentary life style to
a high level of physical activity. All of them were non-smokers, had
normal basal blood glucose concentrations, and had no hyperten-
sion or any metabolic disease. The Body composition, basal serum
glucose and endocrine variables are shown in Table 1. Written
informed consent was obtained from each subject after they
received a full explanation about the study procedures. The study
was performed in accordance with the Helsinki Declaration of
1975, as revised in 2000, being approved by the Ethical
Committee of the University of Las Palmas de Gran Canaria.
General Procedures
The body composition of each subject was determined by DXA
(Hologic QDR-1500, Hologic Corp., software version 7.10,
Waltham, MA) as described elsewhere [25,26]. On a different
day, subjects reported to the laboratory at 8.00 after an overnight
fast. After 10 min rest in the supine position a 20 ml blood sample
was withdrawn and used to measure serum glucose, insulin, leptin,
free and total testosterone, 17b-estradiol, and the soluble leptin
receptor. Then a muscle biopsy was obtained from the middle
portion of the vastus lateralis muscle using the Bergstrom’s
technique with suction, as described elsewhere [27]. The muscle
specimen was cleaned to remove any visible blood fat or
connective tissue. The muscle tissue was immediately frozen in
liquid nitrogen, and stored at 280uC for later analysis. In 5 men
and five women a small piece of subcutaneous adipose tissue was
also sampled 2–3 cm apart from the incision using the same kind
of needle.
Total protein extraction, electrophoresis and Western
blot Analysis
For total protein extraction from skeletal muscle and subcuta-
neous adipose tissue a piece of frozen tissue was homogenized as
described elsewhere [16]. Muscle and fat homogenates were
rotated end over end at 4uC for 60 min, after which they were
centrifuged for 15 min at 20,000 g to remove tissue debris. The
supernatants were harvested and transferred to clean tubes. An
aliquot of each extract was preserved for protein quantification by
bicinchoninic acid assay. Proteins were solubilized in sample buffer
containing 0.0625 mM Tris-HCl, pH 6.8, 2.3% [w/v] SDS, 10%
[v/v] glycerol, 5% [v/v] b-mercaptoethanol, 0.001% [w/v]
bromophenol blue. Equal amounts (50 mg) of each sample were
electrophoresed on 7.5–10% sodium dodecyl sulfate – polyacryl-
amide gel electrophoresis (SDS-PAGE) using the system of
Laemmli [28] and transferred to Hybond-P membranes according
to the method of Towbin et al. [29].
Table 1. Body composition, basal plasma glucose and
endocrine variables.
Men (n=34) Women (n=33)
Mean SD Mean SD
Age (years) 27 6 7 27 6 7
Height (cm) 176.5 6 5.8 * 165.3 6 6.3
Body mass (kg) 76.2 6 11.5 * 60.2 6 8.4
BMI (kg.m22) 24.5 6 3.7 * 22.0 6 2.3
% body fat 18.4 6 7.4 * 28.1 6 7.1
Lean body mass (kg) 58.6 6 5.4 * 40.6 6 3.5
Fat mass (kg) 14.7 6 7.9 * 17.4 6 6.7
Trunk fat mass (kg) 6.9 6 4.8 * 7.0 6 4.5
% fat in trunk 42.8 6 9.4 * 37.6 6 9.0
Glucose (mmol.L21) 4.6 6 0.4 * 4.4 6 0.5
Insulin (pmol.L21) 59.3 6 58.3 53.4 6 24.9
HOMA 1.8 6 2.0 1.5 6 0.7
Leptin (ng.mL21) 4.5 6 4.0 * 15.3 6 8.2
Soluble leptin receptor (ng.mL21) 25.5 6 7.8 * 30.7 6 10.0
Total testosterone (ng.mL21) 7.5 6 3.8 * 1.0 6 0.4
Free testosterone (pg.mL21) 18.0 6 5.7 * 3.7 6 2.1
17b-estradiol 16.0 6 14.4 * 76.9 6 71.0 a
* P,0.05 compared to women. a (n = 28).
doi:10.1371/journal.pone.0003466.t001
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For immunoblotting, membranes were pre-incubated with 5%
blotting grade blocker non-fat dry milk (Bio-Rad Laboratories,
Hercules, CA, USA) in Tris-buffered saline (TBS) with 0.1%
Tween 20 (blotto blocking buffer) for 1 h at room temperature
(20–22uC). To detect the leptin receptor isoforms (OB-Rs),
membranes were incubated with a rabbit polyclonal specific
anti-human OB-R (long form) antibody.
To detect SOCS3 protein expression membranes were
incubated with a rabbit polyclonal specific anti-human SOCS3
antibody. To control for differences in loading and transfer
efficiency across membranes, an antibody directed against alpha-
tubulin was used to hybridize on the same samples. Membrane
incubations with polyclonal rabbit anti-OB-R (diluted 1:2.000 in
blotto blocking buffer) and with polyclonal rabbit anti-SOCS3
(diluted 1:500 in blotto blocking buffer) were performed over night
at 4uC. Membrane incubations with monoclonal mouse anti-
alpha-tubulin (diluted 1:70,000 in blotto blocking buffer) were
performed for 1 h at room temperature.
As control for adipose tissue protein presence in muscular tissue,
a polyclonal rabbit anti-perilipin A antibody was used [30]. To
explore the expression of this protein in human skeletal muscle and
subcutaneous adipose tissue, membranes were blocked with 4%
Bovine Serum Albumin (Sigma, Madrid, Spain) in TBS with 0.1%
Tween 20 (BSA blocking buffer) for 1 h at room temperature.
Membrane incubations with polyclonal rabbit anti-perilipin A
antibody (diluted 1:1,500 in BSA blocking buffer) were performed
for 1 h at room temperature. Antibody-specific labeling was
revealed by incubation with a HRP-conjugated goat anti-rabbit
antibody (1:20,000) or a HRP-conjugated donkey anti-mouse
(1:10,000) antibody both diluted in blotto blocking buffer and
visualized with the ECL chemiluminescence kit (Amersham
Biosciences). Specific bands were visualized with the ECL
chemiluminiscence kit, visualized with the ChemiDoc XRS system
(Bio-Rad Laboratories) and analyzed with the image analysis
program Quantity one (Bio-Rad laboratories). Data are reported
as band intensity of immunostaining values (arbitrary units)
obtained for OB-R, Perilipin or SOCS3 relative to those obtained
for alpha-tubulin. Alpha-tubulin content in the male and female
muscle biopsies was similar (6.5460.44 and 5.4460.42 arbitrary
units of immunostaining band density, respectively, P.0.05).
Glucose and insulin measurements
Serum glucose was measured by the hexokinase method using
Gluco-quant reagents (Roche/Hitachi, 11876899216, Indianapolis,
USA). Serum insulin was measured by an electrochemiluminiscence
immunoassay (ECLIA) intended for use on Modular Analytics
analyzer E170 using Insulin kit reagents (Roche/Hitachi, Indiana-
polis, USA). In a first incubation, insulin from 20 ml serum sample, a
biotinylated monoclonal insulin-specific antibody and a monoclonal
insulin-specific antibody labeled with a ruthenium complex form a
sandwich complex. After addition of streptavidin-coated micropar-
ticles, the complex becomes bound to the solid phase via interaction
of biotin and streptavidin. The reaction mixture is aspirated into the
measuring cell where the microparticles are magnetically captured
onto the surface of the electrode. Unbound substances are then
removed by washing. Application of a voltage to the electrode then
induces chemiluminescent emission which is measured by a
photomultiplier. Results are determined via a calibration curve.
Insulin sensitivity was 0.20 mU/ml.
Assessment of insulin resistance
In each subject, the degree of insulin resistance was estimated at
the baseline by the Homeostasis model assessment (HOMA)
according to the method described by Matthews et al. [31].
Leptin Assays
Serum leptin were determined by Enzyme-Linked Immunosor-
bent Assay (ELISA) (ELx800 Universal Microplate Reader,
Bioteck Instruments Inc, Vermont, USA), using reagent kits from
Linco Research (#EZHL-80SK, Linco ResearchSt. Charles,
Missouri, USA) and following the manufacturer’s instructions.
The sensitivity of the total leptin assays was 0.05 ng/mL. The
intra-assay coefficient variation was 3.8% and the inter-assay
coefficient of variation was 4.4%.
Soluble leptin receptor (sOB-R) Assays
Serum OB-Rs were determined by Enzyme-Linked Immunosor-
bent Assay (ELISA) (ELx800 Universal Microplate Reader, Bioteck
Instruments Inc, Vermont, USA), using reagent kits from R&D
Systems (#DOBR00, R&D, Minneapolis, MN, USA) and following
the manufacturer’s instructions. The sensitivity of the sOB-R assays
was 0.057 ng/mL. The intra-assay coefficient variation was 4.4%
and the inter-assay coefficient of variation was 6.8%.
Total and Free Testosterone Assays
Serum free and total testosterone were determined by Enzyme-
Linked Immunosorbent Assay (ELISA) (ELx800 Universal Micro-
plate Reader, Bioteck Instruments Inc, Vermont, USA), using
reagent kits from IBL (#DB52181 for free testosterone and
#RE52151 for total testosterone, IBL, Hamburg, Germany) and
following the manufacturer’s instructions. The sensitivity of the
free testosterone and total testosterone assays was 0.17 pg/mL and
0.08 ng/mL, respectively. The intra-assay coefficient variation was
6.1% and 3.6%, for free and total testosterone respectively. The
inter-assay coefficient of variation for free and total testosterone
was 7.8% and 7.1%, respectively.
17b-Estradiol Assay
17b-estradiol was measured by a competitive electrochemilu-
miniscence immunoassay (ECLIA) intended for use on Modular
Analytics analyzer E170 using E2 reagents (Roche/Hitachi,
03000079122, Indianapolis, USA). Briefly, by incubating 35 ml
of serum sample with an estradiol-specific biotinylated antibody,
an immunocomplex is formed, the amount of which is dependent
upon the analyte concentration in the sample. After addition of
streptavidin-coated microparticles and an estradiol derivative
labeled with a ruthenium complex, the final antibody-hapten
complex was bound to a solid phase via a biotin-streptavidin
interaction. After remove the unbound substances, application of a
voltage induces chemiluminiscent emission which is measured by a
photomultiplier. Results were determined via a calibration curve
being the analytical sensitivity 18.4 pmol/L.
Statistical analysis
Variables were checked for normal distribution by using a
Kolmogorov-Smirnov test with the Lilliefors correction. When
necessary, the analysis was done on logarithmically transformed
data. Gender differences were determined with ANOVA. To
determine if there was a gender difference in 128 KDa OBR isoform
content in the muscle biopsies we used ANCOVA with perilipin A as
a covariate. The relationship between variables was determined using
linear regression analysis. Values are reported as the mean6standard
deviation. P#0.05 was considered significant. Statistical analysis was
performed using SPSS v.8.0 for Windows (SPSS Inc., Chicago, IL).
Results
Body composition, anthropometrics and hormonal data are
reported in Table 1. Both genders were comparable in age, but
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women were smaller and had lower body mass and higher
percentage of body fat compared to men (all, P,0.05). The
proportion of fat accumulated in the trunk was greater in men
than women (P,0.05).
Serum leptin concentrations, HOMA and sexual
hormones
Although basal serum glucose concentration was 5% lower in
women than men (P,0.05), basal serum insulin concentration and
HOMA were similar in both genders. Serum leptin concentration
was 3.4 times higher in women compared to men (P,0.05) and
this difference remained significant after accounting for the
differences in percentage of body fat. In the whole group, there
was a relationship between the percentage of body fat and the
serum leptin concentration (r = 0.85, P,0.001), and also in each
gender separately (r = 0.81 and r = 0.83, in men and women,
respectively, both P,0.001) (Fig. 1).
In men, but not in women, leptin concentration was inversely
associated to total serum testosterone concentration (r =20.38,
p,0.05). In men, but not in women, serum total and free
testosterone concentration was inversely associated with the
percentage of body fat (r =20.51 and r =20.41, respectively,
both P,0.01). On the other hand, a similar trend was observed
between the logarithm of serum leptin concentration and 17b-
estradiol in women (r =20.34, P= 0.07, n = 28).
The logarithm of HOMA was associated to the serum leptin
concentration in men (r = 0.64, P,0.001) and women (r = 0.63,
P,0.001). In both genders, the logarithm of HOMA was also
associated to the percentage of body fat (r = 0.54 and r = 0.59, in
men and women, both P,0.001). After accounting for the
differences in percentage of body fat the association between the
logarithm of HOMA and serum leptin concentration remained
significant in men (r = 0.57, P,0.05), but not in women (r = 0.31,
P = 0.09). 001).
Expression of leptin receptors in skeletal muscle shows a
gender dimorphism that can not be explained by
differences in serum leptin concentrations or fat tissue
infiltration
Leptin receptor protein expression in skeletal muscle was 41%
(OB-R170, P,0.05) and 163% (OB-R128, P,0.05) greater in
women than men (Fig. 2). No significant between genders
differences in OB-R98 expression were observed (OB-R98;
P = 0.14). There was no relationship between leptin receptors in
skeletal muscle and serum leptin concentration in either group,
even after accounting for differences in serum sOB-R concentra-
tion. In men, muscle OB-R128 protein was inversely associated to
serum free testosterone (r =20.34, P= 0.05). In women, OB-R98
and OB-R128 were inversely associated to total serum testosterone
concentration (r =20.39 and r =20.36, respectively, both
P,0.05), and OB-R128 to serum free testosterone concentration
(r =20.36, P,0.05). No relationship was observed in men or in
women between skeletal muscle OB-R protein content and 17b-
estradiol concentration in serum.
Perilipin A content in skeletal muscle extracts was 93% higher
in women than in men (P,0.001). However, perilipin A content in
the adipose tissue was similar in men (n= 5) and women (n = 5).
OB-R98 and perilipin A were associated (r = 0.42 and r = 0.54, in
men and women, respectively, both P,0.05). In women, but not
in men, perilipin A correlated also with OB-R128 protein in
skeletal muscle (r = 0.50, P,0.01). Nevertheless, gender differences
in OB-R128 expression remained after accounting for differences
in perilipin A content.
The soluble leptin receptor can not be used a surrogate
measure of leptin receptors protein in skeletal muscle
The sOB-R was 20% higher in women than men (P,0.05) and
in men correlated with serum free testosterone concentration
(r = 0.35, P,0.05) (Table 1). There was no relationship between
Figure 1. Relationship between the basal leptin concentration
in serum and body mass index (BMI), whole body fat mass, and
percentage of body fat.
doi:10.1371/journal.pone.0003466.g001
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sOB-R concentration in serum and OB-R isoforms in skeletal
muscle. There was no relationship between HOMA and muscle
leptin receptors or sOB-R.
SOCS3 protein content in skeletal muscle is similar in
healthy men and women and is not related to serum
leptin concentration
SOCS3 protein expression was similar in men and women,
despite the fact that women had about 4-folds higher leptin
concentration than men (Fig. 3). Even when we took the seven
men with the lowest leptin concentration and compared them with
the seven women with the highest leptin concentration, SOCS3
expression was comparable in both groups, despite 40-folds higher
leptin concentration in women than men (Fig. 4). In women, there
was an inverse association between the logarithm of free
testosterone and SCOS3 protein content in skeletal muscle
(r =20.46, P,0.05).
Discussion
In this study we provide further evidence for the presence of the
long (Ob-Rb) and short isoforms of leptin receptor protein in
human skeletal muscle [16]. Immunoblot analysis detected several
immunoreactive proteins with molecular weight of 98, 128 and
170 kDa. The most prominent 128 kDa band has a molecular
weight similar to OB-Rb, based on its amino acid composition
[32]. The smaller 98 kDa protein is likely to correspond to one of
the short leptin receptor isoforms [4]. The 170 kDa has a
molecular weight which corresponds well with the glycosylated
form of OB-Rb [33].
Based on the experimental evidences showing: 1) that in
conditions with chronically elevated leptin concentration, such as
obesity and pregnancy the expression of OB-Rb mRNA is reduced
in the hypothalamus [34], but also in peripheral tissues such as the
liver [34]; 2) that acute leptin administration causes an acute
reduction in the expression of leptin receptors in cell lines [34]; 3)
that prolonged fasting in humans increases OB-R mRNA in
peripheral mononuclear cell [35]; and 4) that administration of
human recombinant leptin in fasting humans blunts the increase in
OB-R in mononuclear cells [35], we hypothesized that women
compared to men will have reduced protein expression of OBR in
skeletal muscle. In contrast with our hypothesis, this study shows
that the 170 and 128 KDa leptin receptors isoforms are more
abundant in female than male skeletal muscle. We have also
observed that the muscle biopsies obtained from women had a
greater amount of perilipin A than those from men. Inasmuch as
Figure 2. Leptin receptor (OB-R) isoform protein expression in
male and female human skeletal muscle. Total Protein extracts
were prepared from male and female muscle and OB-R, perilipin A and
alpha-tubulin protein expression was analyzed by Western blot. A: a
representative immunoblot assay after incubation with a polyclonal
rabbit anti-OB-R antibody specifically raised against de long isoform of
the leptin receptor. B: a representative western blot after incubation
with a polyclonal rabbit anti-perilipin A antibody in the same samples
used in A. C: a representative immunoblot analysis after incubation with
the monoclonal mouse anti-alpha-tubulin antibody in the same
samples used in A. D: densitometric immunosignal values (arbitrary
units of band densities) of OB-R bands relative to those obtained for
alpha-tubulin.
doi:10.1371/journal.pone.0003466.g002
Figure 3. Suppressor of cytokine signaling 3 (SOCS3) protein
content in muscle biopsies obtained from the musculus vastus
lateralis in men and women. A.U.: arbitrary units.
doi:10.1371/journal.pone.0003466.g003
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perilipin A is a protein present in adipocytes and absent in skeletal
muscle fibers, greater perilipin A content in women’s skeletal
muscle biopsies strongly suggest that women have more intermus-
cular adipose tissue than men [36]. These findings only apply to
healthy young humans and different results may be possible in
patients with obesity or metabolic diseases.
Greater intermuscular adipose tissue could explain part of the
gender difference in OB-R128 protein content. Nevertheless, after
accounting for differences in perilipin content, OB-R128 protein
content was still 2.3 times higher in women than men. On the
other hand, adipose tissue contamination in the skeletal muscle
biopsies does not explain the gender differences in OB-R170, since
this isoform was not detected in subcutaneous adipose tissue.
It has been postulated that the sexual dimorphism in leptin
levels reflects reduced leptin sensitivity in women [37] however,
our findings are more compatible with increased leptin sensitivity
in the women’s skeletal muscle, unless the intracellular signaling
pathways are more inhibited in women than men.
Regulation of leptin receptor expression
In agreement with previous studies an inverse association was
observed between leptin concentration and serum testosterone in
men [38], likely caused by an inhibitory effect of leptin on Leydig
cells steroidogenesis [39] and perhaps in testosterone biosynthesis
[40]. In turn, androgens reduce leptin gene transcription in rat
adipocytes [41] and testosterone administration to young men
reduces serum leptin [42]. This effect is likely due a direct
inhibition of leptin production in adipocytes [43], likely combined
an increased leptin clearance rate and shortened plasma leptin
half-life [44].
Although animal studies have shown that 17b-estradiol
administration to ovariectomized rats increases plasma leptin
levels [45] by stimulating leptin production in the adipocytes [41],
leptin also inhibits steroidogenesis in granulosa cells of the ovary
[46], what could explain our findings in regard with the negative
relationship between 17b-estradiol and leptin in women. In
humans, leptin changes in the same direction as 17b-estradiol
during the menstrual cycle [47,48]. Ovarian stimulation with
human FSH (225 IU daily) during an in vitro fertilization program
led to a concomitant rise of plasma leptin coupled to the elevation
of plasma 17b-estradiol [47]. However, postmenopausal women
have higher plasma leptin levels than weight-matched men [48]
and the same as premenopausal women after accounting for
differences in fat mass [17]. The latter implies that at the most
17b-estradiol and androgen could only explain a small part of the
sexual dimorphism in plasma leptin concentrations [17].
Although no relationship was observed in the present study
between 17b-estradiol concentration and skeletal muscles leptin
receptors we can not rule out estrogens as contributors to the
sexual dimorphism in skeletal muscle leptin receptors in humans,
mainly because a punctual isolated determination of basal plasma
concentration of 17b-estradiol give just a rough estimation of the
estrogenic action on the muscles at mid and long term, particularly
fertile women [47,48]. In fact, a recent study has shown that in
ovariectomized rats 17b-estradiol increases OB-Rb protein in
skeletal muscle [22]. Nevertheless our findings indicate that small
differences in 17b-estradiol concentration do not account for
individual differences in muscle leptin receptors in women or men.
Increased skeletal muscle leptin receptors in women
The sOB-R, a circulating soluble form of the leptin receptor is
the main leptin binding protein in blood and determines the free
fraction of circulating leptin [35,49,50]. Administration of leptin to
humans has been reported to elicit small reciprocal changes in
sOB-R plasma concentration [35]. The latter agrees with our
observation of slightly lower serum soluble receptor leptin
concentration in women than men.
Our study indicates that female skeletal muscle has the potential
to respond more to leptin stimulation due to the remarkably
greater abundance of leptin receptors, particularly of the two main
isoforms involved in intracellular leptin signaling (OB-Rb and OB-
Ra) [51]. This could explain why women have an increased
capacity to oxidize fatty acids during prolonged exercise than men
[52,53].
It remains unknown which is the mechanism that determines
this sexual dimorphism in skeletal muscle leptin receptors. Our
study indicates that leptin itself does not explain the sexual
dimorphism in skeletal muscle OB-R expression, since despite a
broad spectrum of leptin concentration is both genders, there was
no correlation between serum leptin concentration and the
abundance of leptin receptors in skeletal muscle, even after
accounting for the differences in serum sOB-R concentration.
Nevertheless, our study provides indirect evidence supporting a
role of serum free testosterone concentration which could explain
12–13% of the variability in skeletal muscle content of the
128 KDa leptin receptor isoform in both genders.
Although leptin and insulin share some intracellular signaling
pathways, our study indicates that insulin (at basal concentration)
does not appear to play a role in the regulation of leptin receptor
expression in skeletal muscles. In agreement, Liu et al. 2007 [20]
reported no significant relationship between OB-Ra or OB-Rb
gene expression in the hypothalamus and liver and serum insulin
concentrations in obese rats.
Soluble leptin receptor does not reflect the amount of
leptin receptors in skeletal muscle
The sOB-R could originate from alternative splicing of the
leptin receptor or from full-length functional leptin receptors
released by enzymatic cleavage, most likely in the liver [5]. In the
latter case, it has been hypothesized that serum sOB-R
concentration could reflect the amount of leptin receptor
Figure 4. Suppressor of cytokine signaling 3 (SOCS3) protein
content in muscle biopsies obtained from the musculus vastus
lateralis in men the seven men with the lowest serum leptin
concentrations and the seven women with the highest serum
leptin concentrations. A.U.: arbitrary units.
doi:10.1371/journal.pone.0003466.g004
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expressed in tissues [54]. Our study, however, shows that sOB-R is
not related to the expression of OB-R isoforms in skeletal muscles.
SOCS3 protein content in skeletal muscles
It has been reported that SOCS-3 mRNA levels are increased in
the skeletal muscle of type 2 diabetic patients compared with
control subjects and correlates with reduced insulin-stimulated
glucose uptake [55]. Skeletal muscle SOCS-3 mRNA is also
increased in obese mice [56]. The study of SOCS3 mRNA levels
in subcutaneous adipose tissue of humans has yielded contradict-
ing results. It has been reported to be increased in a mixed sample
(9 men and 7 women) [55] and to be reduced in obese women
[57]. Thus, it has been suggested that this contradicting results
could have been cause by gender differences in the expression of
SOCS3 in the obese human [57]. Here we report for the first time
SOCS3 protein levels in human skeletal muscle in both genders. In
contrast with our hypothesis, SOCS3 protein is not up-regulated
in women compared to men, implying that if women have some
degree of leptin resistance in their skeletal muscles the mechanisms
is not related to SOCS3 up-regulation.
In summary, this study shows that in healthy young humans
there is a sexual dimorphism in the expression of leptin receptors
in human skeletal muscles, which can not be explained by
differences in circulating leptin or soluble leptin receptor, or
differences in intermuscular adipose tissue. A small part of the
sexual dimorphism could be explained by an inverse relationship
between serum free testosterone concentration and the 128 KDa
isoform of the leptin receptor. No relationship was observed
between estradiol concentration and leptin receptors in skeletal
muscle. The circulating form of the leptin receptor can not be used
as a surrogate measure of the amount of leptin receptors expressed
in skeletal muscles. Despite the fact that the female skeletal muscle
is exposed to very high leptin concentrations, SOCS3 protein
expression was not up-regulated, indicating that if women have
some degree of leptin resistance in their skeletal muscles the
mechanism should be other than SOCS3 up-regulation.
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